|

楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 & O2 s8 t* n& p4 a5 s+ j
( ?, x' u4 D" N6 u! n L5 n今年的ISC大会Late-Breaking Science(重磅研究)已经出炉,国内单位入选情况0 w# D0 E( q+ t8 C8 F4 {* c( I8 G9 F
. A4 V% e. z" S. b; v" g2 b6 ILB2. TransRadial versus transfemoral Arterial access for CErebral angiography
3 F8 B; @1 r0 w: i7 u5 y+ K% gWei Ni, Huashan Hospital, Fudan University, Shanghai, China
I" r9 i) e9 D/ @2 F3 c$ m7 a* U) b4 _4 s
LB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial
& e. T0 C, Q$ h6 L# oXuening Zhang, West China Hospital, Sichuan University, Chendu, China
+ m) ~& ~4 e0 p/ j9 } v
" d8 L, y: P- k+ vLB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
& a/ k" ]; x& A9 WMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China) K" F# [: k# a- Z7 e* s
3 z( i6 {: Y( L0 s# `2 k8 j. M
LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail# L# O4 U( c2 B' N3 ^5 O& i
Xianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China4 b/ x( P) e: q1 w: A
/ `5 N: V) N% j9 v* B1 G7 H$ h& ]LB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours
' ?+ B9 U" X; g- pMin Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
/ ?* e! H# e' q; N: [: M M$ U8 q* ]4 q; a; }) g: k& m+ v9 U$ S
LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial
/ S) m7 C0 W _- h* B2 G/ I" `: tYamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China: q+ }9 P4 R0 O9 e2 ^. U
' O; X, ?# t6 _* r2 o7 {
LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial
* A3 B8 [) [' i3 |Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China$ C- Y. V" n' s
( r( R$ R0 {" \3 {7 J
LB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
) y! A' @. U/ e) S4 a G0 SYarong Ding, Beijing Tiantan Hospital, Beijing, China# T" o/ i I: t5 ?0 {
8 }3 e( m7 @) s+ B8 f祝贺以上单位!+ a4 E9 c; }1 ^0 _: |/ f$ O
|
|